4//SEC Filing
Tessier-Lavigne Marc 4
Accession 0001714899-23-000099
CIK 0001714899other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:06 PM ET
Size
10.0 KB
Accession
0001714899-23-000099
Insider Transaction Report
Form 4
Tessier-Lavigne Marc
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-01+12,649→ 12,649 totalExercise: $30.92Exp: 2033-06-01→ Common Stock (12,649 underlying) - Award
Common Stock
2023-06-01+4,216→ 1,874,572 total
Holdings
- 79,173(indirect: By Trust)
Common Stock
- 78,848(indirect: By Trust)
Common Stock
- 78,848(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
- [F2]Includes 4,216 unvested RSUs.
- [F3]The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.
- [F4]The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.
- [F5]The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.
- [F6]100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001437435
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:06 PM ET
- Size
- 10.0 KB